Back to search
FDAFDA · Food and drugs·Recall number D-0487-2023

Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25

Published April 5, 2023 · Recall initiated: February 8, 2023

Summary

FDA records drug Class II recall D-0487-2023, published April 5, 2023 and initiated February 8, 2023. Recalling firm: Apollo Care; Status: Ongoing; Reported quantity: 215 bags; Lot: Lot #: AC-016581. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: Suspected microbial growth present on external label packaging.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Apollo Care
Distributor
MO
Lot
Lot #: AC-016581
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25 recalled?

Yes. FDA published recall D-0487-2023 on April 5, 2023. Reported hazard: Lack of assurance of sterility: Suspected microbial growth present on external label packaging.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail